Production & Manufacturing

The pharmaceutical sector continues to encounter significant hurdles in small molecule drug development, primarily due to the poor aqueous solubility of emerging chemical entities. As drug discovery pipelines shift toward more complex molecular structures, a high percentage of new...

ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...

The pharmaceutical industry is currently undergoing a significant shift from traditional batch processing toward integrated systems that prioritize speed and consistency. For decades, the production of active pharmaceutical ingredients has relied on segregated steps, where each stage of synthesis...

The expansion of pharmaceutical manufacturing capabilities from a single development site to a network of global production facilities is a complex undertaking that requires meticulous planning and coordination. As the demand for new therapies increases, the ability to replicate...

The pharmaceutical industry is experiencing a profound expansion in the biologic sector, driven by the need for more targeted and effective therapies for chronic diseases. Unlike small molecules, biologics are produced in living systems, which introduces a high degree...

The pharmaceutical sector is entering a new era characterized by the rise of cell and gene therapies, which offer the potential to treat or even cure diseases that were previously managed with lifelong medication. These advanced therapies involve the...

For years, APAC was mainly known for producing medicines on a scale. That picture is changing quickly. In 2026, the region is becoming a place where drugs are discovered, developed, tested, manufactured and increasingly commercialized. Asia now accounts for around 43%...